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Abstract 
Atenolol ((RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide) and 
Hydrochlorothiazide (6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide) are beta1 (β1) 
receptor blocker and diuretic drug respectively; however the combination dosage regime are used for 
cardiovascular therapy. Thus a forced degradation study was carried out upon this combination drug regime 
under acidic and basic environment in order to deconvolute the possible degradation product under specified 
stressed conditions. Under acidic conditions atenolol and hydrochlorothiazide were cleaved into 2-(4-(3-amino-
2- oxopropoxy) phenyl) acetamide and 6-sulphamido benzothiazide. However, under basic conditions, the drugs 
were spliced into 2-(4-(2-hydroxypropoxy) phenyl) acetamide and 2-chloro 4-amino 1, 6-dihydro benzene 
sulphonamide respectively. The degradant peaks were elucidated by HPLC using C18 column with methanol: 
phosphate buffer (70:30 v/v) with a flow rate of 0.5ml/min (UV detection at 226nm).. For quantitative method 
validation, linearity was observed over product concentration range 2µg/ml - 100 µg/ml (r
2
 0.9992) with 
regression equation y=43432x. The products were first identified by LC-MS and further confirmed by FT-IR 
and 1H
1
 NMR.  A specific and sensitive stability-indicating assay method for the simultaneous determination of 
the drugs, its process related impurities and degradation products was developed. 
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1.Introduction 
Atenolol is a selective β1 receptor 
antagonist, a drug belonging to the group of beta 
blockers and primarily used in cardiovascular 
diseases [1]. Atenolol [Fig-1A] is one of the most 
widely used β-blockers in the United Kingdom and 
was once the first-line treatment for hypertension [2-
5]. Hydrochlorothiazide is a diuretic drug of the 
thiazide class that acts by inhibiting the kidneys 
ability to retain water [6]. This reduces the volume of 
the blood, decreasing blood return to the heart and 
thus cardiac output and, by other mechanisms, is 
believed to lower peripheral vascular resistance. 
Hydrochlorothiazide [Fig. 1B] is a calcium-sparing 
diuretic, meaning it can help the body get rid of 
excess water while still keeping calcium. The only 
HPLC method of the combination formulation of 
Atenolol and Hydrochlorothiazide in stability 
indicating method suffers the drawback of splitting of 
the peak and sometimes tailing and fronting effect 
occurred. Literature survey reveals no RP-HPLC 
method for simultaneous estimation and stability 
study of Atenolol and Hydrochlorothiazide in 
combined dosage forms [7-9]. In the present study we 
developed a simple, precise, accurate, selective and 
robust liquid chromatographic method for the 
determination of Atenolol and Hydrochlorothiazide 
in the combined tablet dosage form. Forced 
degradation studies were carried out on the drugs in 
order to generate the potential degradation products 
under acidic and basic stress conditions as per ICH 
guidelines. Four potential degradation products that 
were formed were isolated and characterized. The 
structural characterization of the degradation 
products were determined using Mass Spectroscopy 
(MS), Fourier Transform Infrared Spectroscopy 
(FTIR), and Proton-Nuclear Magnetic Resonance 
(1H NMR). Structural characterization of the major 
degradation products enables one to establish the 
degradation pathway under which the degradation 
products are formed. In addition, synthesis of the 
drug assists in identifying the process related 
impurities. This further helps with the quantitative 
determination of the drug, in the presence of its 
process related impurities and degradation products. 
In the present work, intrinsic stability of Atenolol and 
hydrochlorothiazide were found and a selective, 
precise and accurate HPLC method was developed 
for simultaneous determination of the drugs and its 
process related impurities and degradation products.  
 
Fig-1 A chemical structure of Atenolol 
B chemical structure of Hydrochlrothiazide 
 
2. Experimental 
2.1 Chemical and apparatus  
Atenolol (ATN) working standard has been 
supplied by Cadila Healthcare Pvt. Ltd. (Sikkim, 
India) and Hydrochlorothiazide (HCZ) working 
standard has been supplied by Cadila Healthcare Pvt. 
Ltd. (Sikkim, India). Water (HPLC grade), Methanol 
(HPLC grade), Chloroform, Di-sodium hydrogen 
phosphate, Concentrated hydrochloric acid, Sodium 
hydroxide, Hydrogen peroxide, Glacial acetic acid 
were purchased from Merck India. All chemicals 
were of analytical grade and used as received 
.Combined formulation of Atenolol and 
Hydrochlorothiazide was available as tablet with 
brand name ATN-H with label claimed 50mg 
Atenolol and 25mg Hydrochlorothiazide. System 
configuration of waters HPLC system consisted of 
Water 2489 UV/Visible detector was used throughout 
the analysis. Data analysis and interpretation were 
carried out using EMPOWER software. The analyses 
were carried out on a Phenomenex (Torrance, CA) 
Luna C18 column (250 mm 4.6 mm 10 mm). The 
measurements were carried out at a wavelength of 
226 nm for the analytes. 
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2.2 Experimental Methods 
2.2.1 High Performance Liquid Chromatography 
(HPLC) 
2.2.1.1 Standard solutions and fortification: 20 mg 
of Atenolol and 10 mg of hydrochlorothiazide were 
dissolved in 5ml methanol to produce 2000µg/ml and 
1000µg/ml Atenolol and Hydrochlorothiazide 
respectively. The solution was diluted 1:10 with 
methanol before subjecting to HPLC. 
2.2.1.2 Calibration of Atenolol and 
Hydrochlorothiazide: Standard stock solutions were 
prepared with concentrations of 20:10 µg/ml (v/v), 
40:20 µg/ml (v/v), 60:30 µg/ml (v/v), 80:40 µg/ml 
(v/v) and 100:50 µg/ml (v/v) of ATN and HCZ 
respectively and subsequently subjected to HPLC to 
record “Area under curve” (AUC).. The standard 
curve was constructed by plotting AUC vs. 
concentration. 
2.2.1.3 Estimation of ATN and HCZ in tablet 
formulation by RP-HPLC method: From the stock 
solution of formulation 1ml was pipetted out and the 
volume was made up to 10ml with HPLC grade 
methanol and the solution was 100:50 µg/ml (w/v). 
And from this, 2ml solution was pipetted out and 
transferred to 10ml volumetric flask and the volume 
was made up to the mark with HPLC grade methanol. 
Finally the solution was 20:10 µg/ml (v/v). This 
solution was injected in HPLC system and the AUC 
were recorded. From the regression equation, the 
percentage purity of Atenolol and 
Hydrochlorothiazide was calculated. 
 
3. Validation of RP-HPLC method 
3.1 Accuracy: To study the accuracy, 10 tablets were 
weighed and powdered. Analysis of the same was 
carried out. Recovery studies are carried out by 
standard addition method by adding known amount 
of Atenolol and hydrochlorothiazide (reference 
standard) separately to the reanalyzed sample at three 
different concentration levels i.e. 80%, 100% and 
120% of assay concentration and percentage recovery 
were calculated. 
3.2 Precision: The precision of analytical method 
was studied by performing intra-day and inter-day 
precision. 
3.2.1 Intra-day Precision: Variations of results 
within same day were analyzed. Intra-day precision 
was determined by analyzing the sample solution of 
formulation 20:10 µg/ml (v/v) in linearity range at 
three different time intervals on same day. 
 
3.2.2 Inter-day Precision: Variations of results 
between the days were analyzed. Inter-day precision 
was determined by analyzing the sample solution of 
formulation 20:10 µg/ml (v/v) in linearity range on 
three consecutive days. 
3.3 Repeatability 
The sample solutions of formulation 20:10 
µg/ml (v/v) was prepared and analyzed. The solution 
was analyzed six times and standard deviation was 
calculated. 
3.4 Reproducibility 
The sample solutions of formulation 20:10 
µg/ml (v/v) was prepared and analyzed. The solution 
was prepared and analyzed by Analyst 1 and Analyst 
2 separately. The values obtained were evaluated by 
using F – test and t – test to verify their 
reproducibility. 
3.5 Linearity and Range 
The concentration ranges 10, 20, 30, 40, 50, 
60 and 100 µg/ml for ATN were selected as linearity 
range. Similarly, the concentration ranges 5, 10, 15, 
20, 25, 30 and 50 µg/ml for HCZ were selected as 
linearity range. 
3.6 Limit of Detection and Limit of Quantization 
Detection limit and Quantization limit were 
determined based on the standard deviation of y – 
intercepts of six calibration curves and average slope 
of six calibration curves. 
3.7 Robustness 
The effect of change in the pH of mobile 
phase and flow rate on the retention time, tailing 
factor, theoretical plates and resolution were studied. 
The sample solutions of formulation were prepared 
and analyzed at different pH (3.9, 4.1) of the mobile 
phase and at different flow rate (0.45, 0.55ml/min). 
 
4. Forced degradation studies of tablets 
4.1 For acid degradation: 
Ten tablets were weighed, crushed and 
powdered. Then amount equivalent to 50mg of 
Atenolol and 25mg of Hydrochlorothiazide was taken 
in 100ml round bottomed flask. About 50ml of 1N 
Hydrochloric acid was added to the flask and 
refluxed on heating mantle for 6 hours at 60ºC. 
4.2 For basic degradation 
Ten tablets were weighed, crushed and 
powdered. Then amount equivalent to 50mg of 
Atenolol and 25mg of Hydrochlorothiazide was taken 
in 100ml round bottomed flask. About 50ml of 5N 
Sodium Hydroxide was added to the flask and 
refluxed on heating mantle for 6 hours at 60ºC. 
 
Fig-2 (A) Acid hydrolysis of Hydrochlorothiazide (B) Acid hydrolysis of Atenolol 
(C) Base hydrolysis of Hydrochlorothiazide (d) Base hydrolysis of Atenolol 
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5. Results and discussion  
5.1 Method validation  
This method was validated in accordance to 
ICH guidelines. Recovery studies were carried out by 
standard addition method by adding the known 
amount of Atenolol and hydrochlorothiazide 
separately to the formulation solution at three 
different concentration levels i.e. 80%, 100% and 
120% of assay concentration and percentage 
recoveries were calculated. Percentage recoveries of 
ATN and HCZ were found in the range from 100.07 
– 100.75 % and 104.6 – 105.9 % respectively 
(Supplementary Table 1). Precision of the method 
was determined by %RSD found among intra-day 
precision, inter-day precision and repeatability. It was 
found to be less than 1 % (Supplementary Table 2-5). 
Reproducibility was determined by preparing and 
measuring the standard solution of ATN (20µg/ml) 
and HCZ (10µg/ml) by Analyst 1 and Analyst 2, 
separately. The values obtained were evaluated using 
F-test and t-test to verify their reproducibility 
(Supplementary Table 6-7). Calculated value for t-
test was found to be less than the tabulated (standard) 
value hence no significant difference was observed in 
the result of analysis. Limit of Detection and Limit of 
Quantization were determined from their standard 
deviation of y-intercepts of calibration curves and 
slopes of calibration curves. LOD and LOQ of ATN 
were found to be 0.0007 and 0.0002 µg/ml at 226nm 
respectively. LOD and LOQ of HCZ were found to 
be 0.000062 and 0.000187 µg/ml at 226nm 
respectively. 
For Robustness study, the effect of change 
in the pH of mobile phase and flow rate on retention 
time, tailing factor, theoretical plates and resolution 
were studied. The sample solutions of formulation 
were prepared and analyzed at different pH (3.9, 4.1) 
of the mobile phase and at different flow rate (0.5, 
0.55 ml/min). Percentage RSD of each peak was 
found to be less than 1% (Supplementary Table 8, 9). 
5.2 Forced degradation study 
Atenolol and Hydrochlorothiazide combined 
formulation was exposed to stress condition such as 
acidic and basic and refluxed on heating mantle for 6 
hours. The developed RP-HPLC method was used for 
Quantization of drug in presence of degradation 
products. The amounts of degradation products for 
Atenolol were found to be 9.45% (in acidic 
condition), 34.9% (in basic condition). The amounts 
of degradation products for hydrochlorothiazide were 
found to be 0.5% (in acidic condition), 8.0% (in basic 
condition). The relative retention time of the 
degradants has been shown in Table1. 
 
Table 1 Acid and base degradation products of ATN and HCZ 
Degradant 
Molecular 
weight 
Condition 
of 
degradation 
Relative 
retention 
time 
(Rt) 
Parent drug 
    ATN CZ 
NH2
O
OH2N
O  
2-(4-(3-amino-2-oxopropoxy)phenyl) acetamide 
222 Acid 1.388 min 
 
 
 
 
S
NH
N
O O
S
O O
H2N
 
6-sulfamido Benzothiazide 
264 Acid 3.855 min  
 
 
 
 
 
H2N
O
O
CH3
OH  
2-(4-(2-hydroxypropxy)phenyl) acetamide 
209 Base 2.230min 
 
 
 
 
Cl
H2NO2S
NH2
 
2-chloro 4-amino 1, 6-dihydro Benzene 
sulphonamide 
209 Base 3.535min  
 
 
 
 
 
 
5.3 Characterization of acid degradation products 
The acid and base degradation of drugs 
yielded four degradants. Actually subjecting each 
drug under single stress produced one degradant 
(Table 1). The four degradants were found as 2-(4-(3-
amino-2-oxopropoxy) phenyl) acetamide, 6-
sulfamido benzothiazide, 2-(4-(2-
hydroxypropxy)phenyl) acetamide and 2-chloro 4-
amino 1, 6-dihydro benzene sulphonamide. The 
compound structures were deconvoluted gradually 
through MS, NMR and FT-IR spectra. 
 
5.3.1 Atenolol  
The acid degradation products of Atenolol 
were characterized by Mass, IR and NMR spectra 
Mass spectra of the degraded product showed a 
molecular weight of 222 (determined from the 
molecular ion peak, which is significantly lower than 
the parent molecule (molecular weight 246). A 
fragmentation based database search suggested the 
compound structure to be a free amine. IR spectra 
(KBr, cm
-1
) (Supplementary Fig. S1) of the degraded 
compound elicited structural conformation to the 
compound as mentioned. For example, it showed 
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peaks at 3421 cm
-1
 (-NH2 str, H bonded), 3249 cm
-1
 
(-NH2 wk, free), 1508 cm
-1
(aryl –CH, med-wk), 1560 
cm
-1
 (med-wk, -C=C conjugated, aryl), 1648 cm
-1
 
(str, -CONH2).  No peak for -CH3-CH-CH3- group in 
the product molecule suggests degradation. NMR 
spectra also depict the absence of -CH3-CH-CH3- 
group in the product which also indicates degradation 
(Table 2).   
 
Table 2:  NMR peaks of the degradants from ATN 
 Acid degradant Base degradant 
Sl. No. Proton 
Chemical Shift 
(ppm) 
Proton 
Chemical Shift 
(ppm) 
1. 2 (-NH)  2.351 3 (–CH3) 1.35 
2. 2 (–CH2)  3.474 2 (–CH2) 2.20 
3. 2 (–CH2) 3.597 1 (–OH) 2.35 
4. 2 (–CH2–) 4.264 2 (–CH2–) 3.47 
5. 2 (aromatic proton) 7.103 1 (–CH–, aliphatic) 4.257 
6. 2 (aromatic proton) 7.360 2 (aromatic C–H) (J = 5.1Hz) 7.10 
7. 2(amide amine) 7.536 2 (aromatic C–H) (J = 4.8Hz) 7.36 
   2 (–NH2) 7.56 
 
5.3.2 Hydrochlorothiazide 
The mass spectra for stressed compound 
suggested its molecular mass as 264 whereas IR 
spectra (Supplementary Fig. S2) revealed it is a free 
amine with no chlorine atom: (KBr, cm
-1
) 3365.85 (-
NH2, wk), 3275.87, 3175.00 (-NH-, wk), 2924.24 
(aliphatic –CH, str), 1604.85, 1546.37 (heterocyclic 
ring, med), 1346.39, 1167.85 and 1320.19, 1152.94 (-
SO2NH2, str). The NMR spectra also interpreted the 
compound structure to be a sulphoxide derivative of 
quinazoline (Table 3). 
Table 3: NMR peaks of the degradants from HCZ 
 Acid degradant Base degradant 
Sl. No. Proton 
Chemical Shift 
(ppm) 
           Proton 
Chemical Shift 
(ppm) 
1. 1H (aromatic NH) 6.097           –CH2  2.503 
2. 2H (Aromatic proton) 6.618           – free NH2 3.359 
3. 2H (aromatic proton)  7.357           2(-ArSO2NH2) 6.618 
4. 2H(Sulphonamide)  7.506           1 (Vinylic –CH–    
conjugated) 
7.357 
5. 1H(Aromatic) 8.158           1 (–CH2–, near free NH2, 
undergoing hyperconjugation)  
7.506 
6.             1 (–CH2–, near SO2NH2, 
undergoing hyperconjugation)  
8.514 
 
5.4. Characterization of basic degradation products 
5.4.1 Atenolol 
The mass spectra showed an m/z ratio of 
209 as its molecular weight. The reduction of 
molecular weight from 266 to 209 clearly suggests 
degradation. IR spectra (KBr, cm
-1
, (Supplementary 
Fig. S3) showed peaks at 3630.05 (free –OH, wk), 
3552.31 (H bonded –OH, wk), 3465.95 (H bonded –
NH. med), 2929.28 (-CH, str), 1741.96 (-C=O-NH2), 
1560.06 (conjugated –C=C, med-wk), 847.44 (-
C=CH2, med-wk) which exhibited no peak for –NH–
C–(CH3)2 that was present in original Atenolol 
molecule. This has been further reinforced by NMR 
spectra which also revealed no peak for –NH–C–
(CH3)2 cluster (Table 2).  
 
Fig-3 (A) mass spectra of acid degradants of atenolol (B) mass spectra of acid degradants of 
Hydrochlorothiazide (C) mass spectra of basic degradants of atenolol (D) mass spectra of basic 
degradants of Hydrochlorothiazide  
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5.4.2 Hydrochlorothiazide 
The m/z peak showed in the mass spectra 
deduced the molecular weight of the product to be 
209 which implied a large reduction of mass from the 
parent compound (Hydrochlorothiazide, molecular 
weight 297). This elicited degradation under basic 
condition. Furthermore IR spectra (KBr, cm
-1
, 
Supplementary Fig. S4) depicted absence of ring 
bound [–SO2NHCH3-] group in the product compared 
to the parent; 3379.14 and 3482.73 (free -NH2, wk, 2 
bands), 3090.86 (=C-H, med), 1596.53 (-C=C in 
ring), 2924.56 and 1638.10 (-CH2, str), 588.41 (-Cl, 
str), 1321.84 and 1145.52 (SO2NH2). In addition, 
structure assignment (Table 3) from NMR spectra  
also suggested cleavage of [–SO2NHCH3-] together 
with addition of two hydrogen atoms at 5, 6.  
5.5 Formation of degradation products 
5.5.1Acid degradant of ATN 
ATN undergoes acid guided β-oxidation to 
get converted into β-keto ether which subsequently 
absorbs proton to yield primary amine from 
secondary one by proton induced bond cleavage (Fig. 
4A).  
5.5. 2 Acid degradant of HCZ 
HCZ undergoes free radical [Cl] guided 
dehydrogenation, thus forming carbanion. The 
unpaired electron eventually leads to formation of π 
bonding with the vicinal carbon atom creating 
unsaturation in the ring. The ring again undergoes 
dehydrohalogenation to yield 6-sulfamido 
benzothiazide.  
 
 
Fig-4: A degradation pathway of acid hydrolysis of Atenolol, B Degradation pathway of acid hydrolysis 
of Hydrochlorothiazide 
 
5.5.3 Base degradant of ATN 
Refluxing with alkali, the aqueous medium 
ionizes to generate proton which forms carbonation 
with the α-carbon attached to the amine terminal. In 
order to maintain the ring stability, the bond pair of 
electrons gets shifted to yield 2-(4-(2-
hydroxypropxy) phenyl) acetamide as the degradant 
(Fig. 5A).  
 
 
 
5.5. 4 Base degradant of HCZ 
HCZ undergoes base catalyzed degradation 
in two major steps. First, nitrogen undergoes Lewis 
base type interaction to absorb proton that has been 
generated due to alkali guided reflux. This leads to 
ring exposure to generate free amine. Second, the 
hydroxyl radical attacks the –S terminal to undergo 
auto-oxidation and subsequent release of -SO3H 
terminalized carbonations. Lastly a pair of reduction 
leads to 2-chloro 4-amino 1, 6-dihydro Benzene 
sulphonamide (Fig. 5B).  
 
 
Fig-5: A degradation pathway of basic hydrolysis of Atenolol, B Degradation pathway of basic hydrolysis 
of Hydrochlorothiazide 
.. 
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6. Conclusion 
A force degradation study of atenolol and 
hydrochlorthiazide combination was performed in 
acid and alkaline stress condition to reveal one 
characteristic degradation product from each parent 
under individual condition. Altogether, four 
degradants were found characterized as 2-(4-(3-
amino-2-oxopropoxy) phenyl) acetamide, 6-
sulfamido benzothiazide, 2-(4-(2-
hydroxypropxy)phenyl) acetamide and 2-chloro 4-
amino 1, 6-dihydro benzene sulphonamide. The 
structures were elucidated by LC-MS, 1H
1
-NMR and 
FT-IR spectroscopy. A stability indicating RP-HPLC 
method was also developed to quantitate the 
component drugs in tablet dosage form as well as its 
degradation products. On the whole, the methods are 
found specific, precise, linear, accurate, sensitive, 
robust and suitable. 
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